References UK clinical guidance from the NHS, the British HIV Association (BHIVA), and the British Association for Sexual Health and HIV (BASHH). Last updated: April 2026.
If you’re taking PrEP, PEP or HIV treatment (ART), you may wonder whether HIV tests still give accurate results. The short answer is: standard tests are designed for people not on antiretroviral drugs, and being on these medications can sometimes delay or mask the antibody response that tests rely on. That doesn’t mean testing is pointless — it means the type of test and timing matter.
Here’s what you need to know about HIV test accuracy when antiretroviral drugs are involved.
Order a discreet home HIV test
How HIV Tests Work
Most HIV tests detect antibodies, p24 antigen, or both. After infection, the body takes time to produce these markers. Antiretroviral drugs can interfere with this process.
Testing While on PrEP
PrEP users are tested for HIV every 3 months as part of routine care. If PrEP fails (very rare), the drugs can suppress viral replication enough to delay antibody production. This means:
- Standard 4th-generation tests may take longer to turn positive
- Rapid self-tests (antibody-only) may miss early infection for even longer
- If you have symptoms of acute HIV (fever, rash, sore throat) while on PrEP, tell your clinic — they may run a viral load test
| Test Type | Reliability on PrEP |
|---|---|
| 4th-gen lab test (antibody + p24) | Reliable in most cases; may be delayed in rare breakthrough infections |
| Rapid antibody self-test | May miss breakthrough infection — clinic testing preferred |
| HIV RNA viral load | Most sensitive — used when breakthrough suspected |
Testing While on PEP
PEP is a 28-day course of antiretroviral drugs taken after a possible exposure. While on PEP, HIV tests may not be reliable because the drugs suppress viral replication and delay the immune response. The standard approach is:
- Test at the start of PEP (to confirm you’re HIV-negative)
- Test again at 4-6 weeks after completing PEP
- A final confirmatory test at 3 months post-exposure is sometimes recommended
Testing While on ART (HIV Treatment)
If you’re already HIV-positive and on ART, routine HIV tests (antibody/antigen) will still be positive — HIV antibodies persist for life. What changes on treatment is your viral load, which your clinic monitors separately. ART does not affect the accuracy of standard diagnostic tests for people who are already diagnosed.
If someone stops ART and later tests, their antibody test will still be positive.
What to Do If You’re Worried
- Always tell your clinic if you’re on or have recently taken PrEP or PEP
- Don’t rely on home self-tests alone if you’re on antiretroviral drugs — clinic testing is more appropriate
- If you have symptoms of acute HIV while on PrEP, seek same-day clinic review
Read more: Home HIV testing accuracy | PrEP benefits and risks | False negative results
Frequently Asked Questions
Should I stop PrEP before testing?
No. Continue PrEP as prescribed. Your clinic will use the appropriate test and interpret results in the context of your PrEP use.
Can PEP cause a false negative?
PEP can delay seroconversion, meaning a test taken too soon after finishing PEP may be falsely negative. That’s why you’re tested again at 4-6 weeks and sometimes 3 months after the exposure.
If I’m on ART, will my test always be positive?
Yes. HIV antibodies persist for life even when viral load is undetectable. An antibody test will remain positive regardless of treatment.
Related reading
- How Accurate Are Rapid HIV Tests?
- Injectable HIV Treatment: Everything You Need to Know
- Anonymous STI Testing: What It Means
- Are STI Blood Tests Accurate?
- Before You Get Intimate: Why You Should Ask About STI Testing
Sources
- NHS — Sexual health conditions
- BASHH — UK clinical guidelines for STI management
- British HIV Association (BHIVA) — HIV treatment guidelines
- Terrence Higgins Trust — sexual health information
- UK Health Security Agency — STI surveillance data
Steve Page is a recognised expert on Sexually Transmitted Diseases (STDs) and STD treatments, having published numerous articles in peer-reviewed journals and presented his research at conferences around the world. He has an in-depth understanding of the latest medical research on STDs, and is an advocate for the development of new treatments and protocols to improve the health of those affected. In addition to his research, he has dedicated his career to understanding the causes and symptoms of STDs, as well as how to best treat those impacted.
